FDA Approves Medtronic's Evolut FX+ Transcatheter Aortic Valve Replacement System
With a modified diamond-shaped frame design, the Evolut FX+ offers larger coronary access windows, providing increased space for catheter maneuverability to reach coronary arteries of varying patient anatomies.
Global Pharma | 28/03/2024 | By Abha
FDA Clears PATHFAST hs-cTnI-II Test for Rapid Myocardial Infarction Diagnosis at Point of Care
Prompt diagnosis is crucial in treating patients suspected of having a heart attack.
Global Pharma | 28/03/2024 | By Abha
Akebia Gains FDA Approval of Vafseo Tablets for Treatment of Anemia
Akebia Therapeutics has declared that the US Food and Drug Administration (FDA) has approved Vafseo (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults.
Global Pharma | 28/03/2024 | By Manvi
Integral Molecular Gains ISO 9001 Certification for its MPA Services
Integral Molecular has secured IS0 9001 certification for the quality systems and processes used in its Membrane Proteome Array (MPA) specificity testing services.
<br />
Global Pharma | 28/03/2024 | By Manvi
Greenway Health and DrFirst to Harness Automation Tech to Boost Medication Adherence
Greenway Health has formed a strategic partnership with DrFirst to use the power of automation technology to reduce prescription abandonment and improve medication adherence.
Global Pharma | 28/03/2024 | By Manvi
GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume.
Global Pharma | 27/03/2024 | By Manvi
PhotoPharmics Launches Largest Phototherapy Trial for Parkinson's Disease
The 'Celeste Light for PD Trial' (found at lightforpd.com) represents a significant stride in Parkinson’s disease (PD) treatment, leveraging innovative Spectramax™ technology through the passive and non-invasive Celeste® phototherapy device.
Global Pharma | 27/03/2024 | By Manvi
Lightpoint Performs World's First Bladder Cancer SLN Procedure with SENSEI
Lightpoint Surgical Ltd., an affiliate of Telix Pharmaceuticals Ltd. has achieved a new milestone with world’s first bladder cancer sentinel lymph node (SLN) procedure with SENSEI
Global Pharma | 27/03/2024 | By Manvi
INOVIO Plans to Participate in The Novel Therapeutics Forum at Penn Medicine
INOVIO has announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine
Global Pharma | 27/03/2024 | By Manvi
Sanofi and Cipla Partner to Expand CNS Portfolio Distribution in India
As part of the partnership, Cipla will take on the responsibility of distributing Sanofi India's six CNS brands, including Frisium®, a notable name in the anti-epileptic medication category.
Global Pharma | 27/03/2024 | By Abha
Bridge Biotherapeutics New Venture into Immuno-Oncology with University of Colorado
Bridge Biotherapeutics has forged a research collaboration with Dr. Raul Torres's Lab at the University of Colorado School of Medicine.
Global Pharma | 27/03/2024 | By Manvi
AstraZeneca Pharma India Names Vinay Sharma as Business Unit Head for Rare Disease Unit
Sharma is a Post?Graduate in Marketing Management and Business Administration with over 23 years of industry experience.
Global Pharma | 27/03/2024 | By Abha
Teva UK and Closed Loop Medicine Collaborates to Advance Development of Personalised Medicines
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.
Drug Discovery & Development | 26/03/2024 | By Manvi
STEMCELL Technologies announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
Global Pharma | 26/03/2024 | By Manvi
Andelyn Biosciences Partners with Grace Science to Accelerate Development of NGLY1 Gene Therapy
NGLY1 Deficiency is a severe, life-threatening condition characterized by developmental delay, cognitive impairment, movement disorders, and other debilitating neurological symptoms.
Global Pharma | 26/03/2024 | By Abha
Novo Nordisk to Acquire Cardior Pharmaceuticals for up to EUR 1.025 Billion
At the heart of the acquisition is Cardior's lead compound, CDR132L, currently in phase 2 clinical development for the treatment of heart failure.
Global Pharma | 26/03/2024 | By Abha
Poseida Therapeutics Welcomes Syed Rizvi as New Chief Medical Officer
Poseida Therapeutics, Inc. has appointed Syed Rizvi, MD, as Chief Medical Officer effective April 1, 2024.
<br />
Global Pharma | 26/03/2024 | By Manvi
Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201
Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety
Drug Discovery & Development | 26/03/2024 | By Manvi
Scivita Medical Signs Extended Partnership with Boston Scientific
Scivita Medical Technology Co., Ltd. has signed an expanded strategic cooperation arrangement with Boston Scientific.
Global Pharma | 26/03/2024 | By Manvi
Astellas Pharma Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI™ (enzalutamide) as monotherapy.
Global Pharma | 22/03/2024 | By Manvi
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy